Silo Pharma, Inc. Annual Net Income (Loss) Attributable to Parent in USD from 2011 to 2023

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Silo Pharma, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2011 to 2023.
  • Silo Pharma, Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$929K, a 40.7% decline year-over-year.
  • Silo Pharma, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$3.78M, a 10.8% increase year-over-year.
  • Silo Pharma, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$3.7M, a 5.32% increase from 2022.
  • Silo Pharma, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$3.91M, a 200% decline from 2021.
  • Silo Pharma, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was $3.9M.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$3.7M +$208K +5.32% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-25
2022 -$3.91M -$7.81M -200% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-25
2021 $3.9M +$6.94M Jan 1, 2021 Dec 31, 2021 10-K 2023-03-24
2020 -$3.04M -$2.02M -200% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-28
2019 -$1.01M -$43.8K -4.52% Jan 1, 2019 Dec 31, 2019 10-K/A 2021-05-17
2018 -$969K -$1.33M -372% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-20
2017 $357K Jan 1, 2017 Dec 31, 2017 10-K 2019-04-04
2012 -$39.4K +$10.4K +20.8% Jan 1, 2012 Dec 31, 2012 10-K 2014-03-31
2011 -$49.8K Jan 1, 2011 Dec 31, 2011 10-K 2014-03-31
* An asterisk sign (*) next to the value indicates that the value is likely invalid.